Citation Impact
Citing Papers
An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus
2007
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
Exercise training increases size of hippocampus and improves memory
2011 Standout
Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review
2006
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Mechanisms and Functional Implications of Adult Neurogenesis
2008 Standout
Nano-sized MRI contrast agents with dendrimer cores
2005
A convenient synthesis of bifunctional chelating agents based on diethylenetriaminepentaacetic acid and their coordination chemistry with yttrium(III)
1991
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
Preoperative Breast Cancer Staging: MR Imaging of the Axilla with Ultrasmall Superparamagnetic Iron Oxide Enhancement
2002
Openings between Defective Endothelial Cells Explain Tumor Vessel Leakiness
2000
β-Phosphorylated Five Membered Ring Nitroxides. Synthesis and EPR Study
1993
Rotational Dynamics Account for pH‐Dependent Relaxivities of PAMAM Dendrimeric, Gd‐Based Potential MRI Contrast Agents
2005
The bath ankylosing spondylitis radiology index (BASRI): A new, validated approach to disease assessment
1998
Imaging in the era of molecular oncology
2008 StandoutNature
Tumor angiogenesis: past, present and the near future
2000
Ranibizumab for Neovascular Age-Related Macular Degeneration
2006 Standout
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
2004 Standout
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
1998 StandoutNatureNobel
NUCLEIC ACID HYBRIDIZATION ACCOMPANIED WITH EXCIMER FORMATION FROM TWO PYRENE‐LABELED PROBES
1995
Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer
2003 Standout
Gadolinium(III) Di- and Tetrachelates Designed for in Vivo Noncovalent Complexation with Plasma Proteins: A Novel Molecular Design for Blood Pool MRI Contrast Enhancing Agents
1995
New insights into nNOS regulation of vascular homeostasis
2005 StandoutNobel
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Angiogenesis in cancer and other diseases
2000 StandoutNature
Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1
2006 StandoutNobel
The biology of VEGF and its receptors
2003 Standout
Scaling down imaging: molecular mapping of cancer in mice
2002
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
2011 Standout
Glycans in cancer and inflammation — potential for therapeutics and diagnostics
2005 StandoutNobel
Molecular Imaging
2001
Lanthanide luminescence for functional materials and bio-sciences
2009 Standout
Tumor microvascular characterization using ultrasmall superparamagnetic iron oxide particles (USPIO) in an experimental breast cancer model
2001
Synthesis and characterization of branched poly(l-glutamic acid) as a biodegradable drug carrier
2003
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial
2002 Standout
Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications
2003
Vascular-specific growth factors and blood vessel formation
2000 StandoutNature
Alkynylpyrenes as Improved Pyrene‐Based Biomolecular Probes with the Advantages of High Fluorescence Quantum Yields and Long Absorption/Emission Wavelengths
2005
Pyrene binary probes for unambiguous detection of mRNA using time-resolved fluorescence spectroscopy
2006
Analysis of subcutaneous angiogenesis by gradient echo magnetic resonance imaging
1998
Clinical applications of angiogenic growth factors and their inhibitors
1999
Imaging of angiogenesis: from microscope to clinic
2003
Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?
2006 Standout
Understanding biophysicochemical interactions at the nano–bio interface
2009 Standout
Clinical imaging of cancer metastasis
2000
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
2012 StandoutNobel
Angiogenesis as a therapeutic target
2005 StandoutNature
Tumor Angiogenesis
2008 Standout
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
Upconversion Nanoparticles: Design, Nanochemistry, and Applications in Theranostics
2014 Standout
Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement
2000
Pharmacology and Pharmacodynamics of Bevacizumab as Monotherapy or in Combination with Cytotoxic Therapy in Preclinical Studies
2005
Metal-Initiated Amination of Alkenes and Alkynes
1998 Standout
Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications
1999 Standout
Signaling Recognition Events with Fluorescent Sensors and Switches
1997 Standout
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Electrochemistry Using Self-Assembled DNA Monolayers on Highly Oriented Pyrolytic Graphite
2006
Hydroamination: Direct Addition of Amines to Alkenes and Alkynes
2008 Standout
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
The Sonogashira Reaction: A Booming Methodology in Synthetic Organic Chemistry
2007 Standout
Fluorescence Lifetime Measurements and Biological Imaging
2010 Standout
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
SYNTHESIS OF DIALKYL (PYRROLIDIN-2-YL)-PHOSPHONATES BY MERCURIC ACETATE PROMOTED CYCLIZATION OF α-AMINOALKENYLPHOSPHONATES. REGIO AND STEREOCHEMICAL ASPECTS
1994
An Improved Reduction Procedure in the Synthesis of Substituted Pyrrolidines via An Aminomercuration/Reduction Sequence of Primary Alkenylamines
1996
Combined Optical and MR Bioimaging Using Rare Earth Ion Doped NaYF4 Nanocrystals
2009
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Magnetic Resonance Imaging of Inducible E-Selectin Expression in Human Endothelial Cell Culture
2001
Reduction of vascular and permeable regions in solid tumors detected by macromolecular contrast magnetic resonance imaging after treatment with antiangiogenic agent TNP-470.
2003
Upconversion Luminescent Materials: Advances and Applications
2014 Standout
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
Effect of varying the molecular weight of the MR contrast agent Gd‐DTPA‐polylysine on blood pharmacokinetics and enhancement patterns
1994
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Peptide blockade of HIFα degradation modulates cellular metabolism and angiogenesis
2002 StandoutNobel
Anti-Vascular Endothelial Growth Factor Monoclonals in Non-Small Cell Lung Cancer
2004
Molecular Dynamics of Ion−Chelate Complexes Attached to Dendrimers
1996 StandoutNobel
Advanced Carbon Electrode Materials for Molecular Electrochemistry
2008 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Genes Expressed in Human Tumor Endothelium
2000 StandoutScience
β-Phosphorylated cyclic nitroxides. 2. Synthesis of pyrrolidin- and piperidin-2-yl phosphonates and the corresponding stable nitroxides.
1991
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents
2017 StandoutNobel
Application of a Macromolecular Contrast Agent for Detection of Alterations of Tumor Vessel Permeability Induced by Radiation
2004
Works of Jeffry S. Mann being referenced
Quantification of liver blood volume: comparison of ultra short ti inversion recovery echo planar imaging (ulstir‐epi), with dynamic 3d‐gradient recalled echo imaging
1995
Quantification of tissue plasma volume in the rat by contrast‐enhanced magnetic resonance imaging
1993
Assessing tumor angiogenesis using macromolecular MR imaging contrast media
1997
Mapping Abnormal Synovial Vascular Permeability in Temporomandibular Joint Arthritis in the Rabbit Using MRI
1996
Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density.
1996
Tumor angiography using high-resolution, three-dimensional magnetic resonance imaging: Comparison of gadopentetate dimeglumine and a macromolecular blood-pool contrast agent
1995
A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution
1997
Contrast-enhanced MR imaging assessment of tumor capillary permeability: effect of irradiation on delivery of chemotherapy.
1996
Stability of Gadolinium Complexes In Vitro and In Vivo
1993
Magnetic Resonance Imaging Detects Suppression of Tumor Vascular Permeability After Administration of Antibody to Vascular Endothelial Growth Factor
1998
Synthesis and properties of an oligodeoxynucleotide modified with a pyrene derivative at the 5'-phosphate
1992
Molecular amplifiers: synthesis and functionalization of a poly(aminopropyl)dextran bearing a uniquely reactive terminus for univalent attachment to biomolecules
1992
Novel nitroxides for spin-labelling, -trapping, and magnetic resonance imaging applications
1990
Chelating ligands functionalized for facile attachment to biomolecules. A convenient route to 4-isothiocyanatobenzyl derivatives of diethylenetriaminepentaacetic acid and ethylenediaminetetraacetic acid
1990